Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Chemicals

Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for agrochemicals, medical, glass, cosmetics, etc. Industries. The company was founded in 2003 and is based in Chennai, India.

Revenue projections:

Revenue projections for ACI
Revenue projections for ACI

ACI's revenue projections show a decrease from last year, which tends to make investors more cautious. This could have a negative impact on the company's bottom line, as lower revenues typically suggest reduced profitability and growth potential, prompting concern among investors.

Financial Ratios:

currentRatio 3.000000
forwardPE 16.156332
debtToEquity 14.782000
earningsGrowth 0.858000
revenueGrowth -0.030000
grossMargins 0.964560
operatingMargins 0.167460
trailingEps 13.840000
forwardEps 45.220000

Archean Chemical Industries Limited's current ratio of 3.0, indicating that the company can meet its short-term debt obligations with ease. This high liquidity level is a positive sign, as Archean Chemical Industries Limited has enough cash and current assets to handle its immediate liabilities comfortably.
With ACI's Forward PE in a favorable range, the stock appears reasonably priced compared to its earnings. This suggests that it's not overpriced and there is room for growth, providing an encouraging opportunity for investors seeking future value increases.
ACI's low Debt-to-Equity ratio indicates the company is not over-leveraged. By limiting its dependence on debt, ACI reduces its financial risk and demonstrates a strong capital structure, making it a more stable investment option for those wary of excessive borrowing.
With a forward EPS greater than its trailing EPS, ACI is forecasted to be more profitable this year than last. This growth expectation reflects confidence in the company's earnings potential and suggests an improving financial trajectory for the year ahead.

Price projections:

Price projections for ACI
Price projections for ACI

The current price of ACI, in relation to its projections, presents a neutral outlook. There are no discernible risks or opportunities at this stage, indicating that investors may need to await further developments to make informed decisions regarding their positions in the stock.

Insider Transactions:

Insider Transactions for ACI
Insider Transactions for ACI


1 separate transactions to buy Archean Chemical Industries Limited were completed, while market price hovered around 627.5499877929688.There were no buy transactions during the given period.More sells than buys at ACI's current price levels suggest potential weakness. If this trend continues, the stock may experience further price declines as selling pressure increases.

Recommendation changes over time:

Recommendations trend for ACI
Recommendations trend for ACI


Analysts' buy bias for ACI signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to ACI, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.